marketwatch
Viking Therapeutics posts positive results for oral weight-loss drug. Analysts remain unanimous the stock’s a buy.
MarketWatch • 2 YEARS AGO
Momentum stocks are outperforming S&P 500 by widest margin since 2008. Investors should be concerned.
MarketWatch • 2 YEARS AGO
Easter falls really early this year. Why that could cost retailers $1.6 billion.
MarketWatch • 2 YEARS AGO
Trump’s Truth Social sees stock rally again, but it sent a warning to investors
MarketWatch • 2 YEARS AGO
S&P issues negative outlook on five U.S. regional banks due to risky office space exposure
MarketWatch • 2 YEARS AGO
Merck’s stock rallies toward a record after FDA OKs arterial-hypertension drug
MarketWatch • 2 YEARS AGO
How has this $25 billion fund beaten the S&P 500? Patience — and preparing for ‘the next big thing.’
MarketWatch • 2 YEARS AGO
Boeing is paralyzed, and this failing of its executives and directors is to blame
MarketWatch • 2 YEARS AGO
Amazon and other tech giants can’t afford to lose power — so they’re making it
MarketWatch • 2 YEARS AGO